RENAL CELL CARCINOMA (KIDNEY CANCER)

This is the first study in humans testing a new drug called KO-2806, both alone and combined with other cancer therapies. It aims to find safe doses and see early signs of effectiveness in 300 adults with advanced solid tumors that have specific genetic changes, including certain…

This study is for people whose kidney cancer has spread to only a few other places in the body. It tests if adding a very precise, high-dose radiation treatment to standard drug therapy works better than the drugs alone. The goal is to see if this combination can keep the cancer …

This study is testing whether a digital app that lets patients report their symptoms weekly helps doctors better manage side effects for people taking two cancer drugs (cabozantinib and nivolumab) for advanced kidney cancer. It involves 83 adults who are starting this specific dr…

This study is testing whether it's practical to add a quick abdominal scan to the existing NHS lung cancer screening program for high-risk smokers. It will see if offering the extra scan affects people's decision to attend screening and if the process can be done without adding t…

This study is preparing for future cancer treatment trials by collecting information and materials from patients. Researchers will analyze tumor tissue from people with advanced solid tumors and collect their white blood cells through a procedure called apheresis. The collected c…

This study aims to find out if measuring a protein called Galectin-3 in the blood can help predict how patients with certain cancers will respond to immunotherapy drugs (PD-1/PD-L1 inhibitors). Researchers will observe 300 adults with kidney, lung, liver, or bladder cancer who ar…

This study aims to better understand and measure the fear of cancer returning in people who have had surgery for kidney cancer, and in their partners. First, a panel of patients and partners will help researchers design the best way to ask about this fear during follow-up care. T…